JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laufer, R.
Right arrow Articles by Selinger, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laufer, R.
Right arrow Articles by Selinger, Z.

Desensitization with a selective agonist discriminates between multiple tachykinin receptors

R Laufer, C Gilon, M Chorev and Z Selinger

Department of Biological Chemistry, Hebrew University of Jerusalem, Israel.

We have reported recently the development of substance P analogs which selectively activate different tachykinin receptor types. These compounds, namely septide [( pGlu6, Pro9]substance P6-11 hexapeptide), which preferentially acts on the NK-1 (SP-P) receptor, and senktide (succinyl-[Asp6,Me-Phe8] substance P (6-11) hexapeptide), which selectively acts on the NK-3 (or SP-N) receptor, were now used to identify the tachykinin receptors present in several smooth muscle systems. Septide as well as senktide were found to be devoid of activity in the electrically stimulated rat vas deferens, showing that, in this preparation, which is the prototype NK-2 (or SP-E) system, tachykinin-induced contraction is not mediated via NK-1 or NK-3 receptors. In contrast, senktide did evoke contraction of the isolated rat duodenum, demonstrating that this tissue, which had been classified previously as a NK-2 preparation, also contains NK-3 receptors. After desensitization of NK-3 receptors by treatment with a desensitizing concentration of senktide, the rank order of tachykinin potencies in contracting the isolated rat duodenum corresponded to that of a typical NK-2 system. In the guinea pig ileum in which the tachykinin-evoked contraction is mediated by both NK-1 and NK-3 receptors, desensitization of NK-3 receptors unmasked a typical NK-1 response. Inasmuch as selective desensitization of both NK-1 and NK-3 sites abolished the tachykinin-induced response of the guinea pig ileum, it seems that this preparation does not contain NK-2 receptors. Our results show that selective agonists can be used to perform independent assays of several tachykinin receptors present within the same tissue preparation.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 245, Issue 2, pp. 639-643, 05/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
D. Moriarty, N. Selve, A. W. Baird, and J. Goldhill
Potent NK1 antagonism by SR-140333 reduces rat colonic secretory response to immunocyte activation
Am J Physiol Cell Physiol, April 1, 2001; 280(4): C852 - C858.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
E. F. Grady, P. Baluk, S. Bohm, P. D. Gamp, H. Wong, D. G. Payan, J. Ansel, A. L. Portbury, J. B. Furness, D. M. McDonald, et al.
Characterization of Antisera Specific to NK1, NK2, and NK3 Neurokinin Receptors and their Utilization to Localize Receptors in the Rat Gastrointestinal Tract
J. Neurosci., November 1, 1996; 16(21): 6975 - 6986.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1988 by the American Society for Pharmacology and Experimental Therapeutics.